Biocon’s Pertuzumab Biosimilar Receives Positive CHMP Opinion Under EMA’s Tailored Clinical Approach JD Supra 6h
IPO Ahead! Electrical products maker Biocon Electric files draft papers with Sebi The Times of India 4d
USPTO Director Issues Opinion Explaining Denial of Biocon Post-Grant Review Petition (PGR) Challenging EYLEA® Patent JD Supra 7d
Squires Says Biocon Challenge To Eylea Patent Filed Too Late Law360 23:47 Fri, 25 Sep Article paywall
Adding epcoritamab to R-CHOP cut Lymphoma progression or death risk by 51% in topline Phase 3 trial results Medical Daily 4h Cancer AbbVie Cancer Treatment
AI is moving into venture capital investment decision-making BioWorld 6h AI Pharma IT Article paywall
FDA says safety review of abortion pill will continue into next year HuffPost (US) 8h Mifepristone FDA Lifestyle
Argenx’s celiac win, sjögren’s setback put autoimmune pipeline in focus Scrip Pharma Intelligence 10h
